<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-dextrose.xml</id>
  <title>Recalls Watch: Dextrose</title>
  <link rel="self" href="https://recalls.watch/feed/substance-dextrose.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-09-16T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99679/</id>
    <title>Baxter Healthcare Corporation: Dextrose Injection</title>
    <link href="https://recalls.watch/recall/fda/99679/"/>
    <updated>2026-09-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-baxter-issues-voluntary-nationwide-recall-one-lot-70-dextrose-injection-due-pote/</id>
    <title>Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-baxter-issues-voluntary-nationwide-recall-one-lot-70-dextrose-injection-due-pote/"/>
    <updated>2026-08-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Potential presence of particulate matter identified as stainless steel particles in the solution.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98829/</id>
    <title>Fresenius Medical Care Holdings, Inc.: DELFLEX and 1 more</title>
    <link href="https://recalls.watch/recall/fda/98829/"/>
    <updated>2026-05-13T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: Potential leaks from perforations in bags.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98693/</id>
    <title>B BRAUN MEDICAL INC: Sterile Water for Injection USP and 3 more</title>
    <link href="https://recalls.watch/recall/fda/98693/"/>
    <updated>2026-04-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98581/</id>
    <title>Fresenius Kabi USA, LLC: 0.45% Sodium Chloride Injection and 13 more</title>
    <link href="https://recalls.watch/recall/fda/98581/"/>
    <updated>2026-04-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94846/</id>
    <title>Baxter Healthcare Corporation: Dianeal Low Calcium</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94846"/>
    <updated>2024-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93690/</id>
    <title>Fresenius Medical Care Holdings, Inc.: DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93690"/>
    <updated>2024-01-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Sterility Assurance</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/77111/</id>
    <title>Hospira Inc.: Infant 25% DEXTROSE Injection</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=77111"/>
    <updated>2017-05-31T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter: human hair found within an internal sample syringe.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/73313/</id>
    <title>Hospira Inc.: Normosol-M and 5% Dextrose</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=73313"/>
    <updated>2016-03-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Incorrect or Missing Lot and/or Exp Date: Confirmed customer report of an incorrect expiration date printed on the primary container labeled &quot;01AUG1017&quot; rather than &quot;01AUG2017&quot;.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
